| [1] |
Haanen JBAG, Carbonnel F, Robert C, et al. Management of toxi-cities from immunotherapy:ESMO clinical practice guidelines for diagnosis,treatment and follow-up[J]. Ann Oncol, 2017, 28(suppl_4):iv119-iv142.
|
| [2] |
马艳梅, 刘玉, 倪宏, 等. 免疫检查点抑制剂治疗相关不良反应的护理[J]. 护理研究, 2021, 35(16):2966-2970.
|
|
Ma YM, Liu Y, Ni H, et al. Nursing care of adverse reactions related to immune checkpoint inhibitors treatment[J]. Chin Nurs Res, 2021, 35(16):2966-2970.
|
| [3] |
刘运炜, 陈燕欣, 曾治民, 等. 免疫检查点抑制剂相关心肌炎的研究进展[J]. 中国肺癌杂志, 2021, 24(9):668-672.
|
|
Liu YW, Chen YX, Zeng ZM, et al. Research progress of immune checkpoint inhibitor-associated myocarditis[J]. Chin J Lung Cancer, 2021, 24(9):668-672.
|
| [4] |
朱纪芳, 汪小华, 陆敏霞. 2例重症心肌炎并发急性胰腺炎患者的护理[J]. 中华护理杂志, 2014, 49(9):1150-1152.
|
|
Zhu JF, Wang XH, Lu MX. Nursing care of 2 patients with severe myocarditis complicated by acute necrotic pancreatitis[J]. Chin J Nurs, 2014, 49(9):1150-1152.
|
| [5] |
中国抗癌协会整合肿瘤心脏病学分会, 中华医学会心血管病学分会肿瘤心脏病学学组, 中国医师协会心血管内科医师分会肿瘤心脏病学专业委员会, 等. 免疫检查点抑制剂相关心肌炎监测与管理中国专家共识(2020版)[J]. 中国肿瘤临床, 2020, 47(20):1027-1038.
|
|
Society of Integrative Cardio-Oncology China Anti-Cancer Association,the Cardio-Oncology Group of the Chinese Society of Cardiovascular Diseases of Chinese Medical Association,Chinese College of Cardiovascular Physicians Specialized Committee on Cardio-Oncology Chinese Medical Doctor Association, et al. Chinese expert consensus on the surveillance and management of immune checkpoint inhibitor-related myocarditis(2020 version)[J]. Chin J Clin Oncol, 2020, 47(20):1027-1038.
|
| [6] |
Maisch B, Ruppert V, Pankuweit S. Management of fulminant myocarditis:a diagnosis in search of its etiology but with therapeutic options[J]. Curr Heart Fail Rep, 2014, 11(2):166-177.
DOI
URL
|
| [7] |
邱小英, 石泽亚, 张艳, 等. 1例免疫检查点抑制剂相关暴发性心肌炎患者的护理[J]. 中华护理杂志, 2022, 57(14):1744-1748.
DOI
|
|
Qiu XY, Shi ZY, Zhang Y, et al. Nursing care of a patient with immune checkpoint inhibitor-associated fulminant myocarditis[J]. Chin J Nurs, 2022, 57(14):1744-1748.
|
| [8] |
江莹, 黎万汇, 陈莹莹, 等. 经外周静脉输注血管活性药物风险管理范围的综述[J]. 中华护理杂志, 2021, 56(7):1105-1110.
DOI
|
|
Jiang Y, Li WH, Chen YY, et al. A scoping review on risk ma-nagement of peripheral vasoactive medication[J]. Chin J Nurs, 2021, 56(7):1105-1110.
|
| [9] |
糖皮质激素急诊应用共识专家组. 糖皮质激素急诊应用专家共识[J]. 中华急诊医学杂志, 2020, 29(6):765-772.
|
|
Consensus expert group on emergency use of glucocorticoids. Expert consensus on emergency use of glucocorticoids[J]. Chin J Emerg Med, 2020, 29(6):765-772.
|
| [10] |
李海燕, 李蓉, 植艳茹, 等. 中老年患者院内发生静脉血栓栓塞症风险预测模型的研究[J]. 中华护理杂志, 2020, 55(1):68-73.
DOI
|
|
Li HY, Li R, Zhi YR, et al. Study on risk prediction model of in-hospital venous thromboembolism in middle-aged and elderly patients[J]. Chin J Nurs, 2020, 55(1):68-73.
|
| [11] |
Chen DY, Huang WK, Wu CC, et al. Cardiovascular toxicity of immune checkpoint inhibitors in cancer patients:a review when cardiology meets immuno-oncology[J]. JFMA, 2019, 119(10):1461-1475.
|
| [12] |
冯波, 叶秀琳, 邢星敏, 等. 葡萄糖酸氯己定抗菌敷料联合氯己定擦浴在预防股静脉血滤导管相关血流感染中的效果研究[J]. 中国实用护理杂志, 2018, 34(15):1182-1185.
|
|
Feng B, Ye XL, Xing XM, et al. Effectiveness of chlorhexidine gluconate gel dressings combined with chlorhexidine wipe bath on femoral venous central line-associated bloodstream infections in continue renal replacement therapy[J]. Chin J Pract Nurs, 2018, 34(15):1182-1185.
|
| [13] |
叶桂连, 吴秋敏, 陈淑绮, 等. 心肺联合移植术后患者早期阶梯式运动康复方案的制订及实践[J]. 中华急危重症护理杂志, 2021, 2(3):221-225.
|
|
Ye GL, Wu QM, Chen SQ, et al. Development and practice of early progressive exercise rehabilitation program in patients after combined heart and lung transplantation[J]. Chin J Emerg Crit Care Nurs, 2021, 2(3):221-225.
|
), 胡蕾(